MicroRNA-155-5p Targets JADE-1, Promoting Proliferation, Migration, and Invasion in Clear Cell Renal Cell Carcinoma Cells

MicroRNA-155-5p Targets JADE-1, Promoting Proliferation, Migration, and Invasion in Clear Cell Renal Cell Carcinoma Cells

Clear cell renal cell carcinoma (ccRCC) incidence has been rising in recent years, with strong association between differential microRNA (miRNA) expression and neoplastic progression. Specifically, overexpression of miR-155-5p has been associated with promoting aggressive cancer in ccRCC and other c...

Full description

Bibliographic Details
Main Authors:	Thomas Kalantzakos, Kailey Hooper, Sanjna Das, Travis Sullivan, David Canes, Alireza Moinzadeh, Kimberly Rieger-Christ
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	International Journal of Molecular Sciences
Subjects:	miR-155-5p Jade-1 Clear cell renal cell carcinoma (ccRCC) metastasis Von-Hippel Lindau (VHL) microRNAs
Online Access:	https://www.mdpi.com/1422-0067/24/9/7825

Similar Items

The Clinical and Molecular Features in the VHL Renal Cancers; Close or Distant Relatives with Sporadic Clear Cell Renal Cell Carcinoma?
by: Alessandra Cinque, et al.
Published: (2022-10-01)

Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma
by: Patrick Schuhmacher, et al.
Published: (2019-10-01)

Hypoxia-Inducible Factor-2 Alpha as a Novel Target in Renal Cell Carcinoma
by: WonSeok W. Choi, et al.
Published: (2021-04-01)

Development and validation of a VHL-associated immune prognostic signature for clear cell renal cell carcinoma
by: Jin Zhang, et al.
Published: (2020-12-01)

MiRNA-424-5p Suppresses Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma and Attenuates Expression of O-GlcNAc-Transferase
by: Thomas J. Kalantzakos, et al.
Published: (2021-10-01)

Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma
by: Virginia Albiñana, et al.
Published: (2022-01-01)

VHL-dependence of EHHADH Expression in a Human Renal Cell Carcinoma Cell Line
by: Julia Felicitas Pilz, et al.
Published: (2024-01-01)

Downstream Targets of VHL/HIF-α Signaling in Renal Clear Cell Carcinoma Progression: Mechanisms and Therapeutic Relevance
by: Sonia Mazumder, et al.
Published: (2023-02-01)

Correlation analysis of VHL and Jade-1 gene expression in human renal cell carcinoma
by: Xiao-fen Wu, et al.
Published: (2016-01-01)

Genomic profiles of renal cell carcinoma in a small Chinese cohort
by: Sheng Tai, et al.
Published: (2023-06-01)

CLN5 in heterozygosis may protect against the development of tumors in a VHL patient
by: Isabel de Rojas-P, et al.
Published: (2020-06-01)

SCD5 Regulation by VHL Affects Cell Proliferation and Lipid Homeostasis in ccRCC
by: Athina Ganner, et al.
Published: (2023-03-01)

VHL L169P Variant Does Not Alter Cellular Hypoxia Tension in Clear Cell Renal Cell Carcinoma
by: Junhui Hu, et al.
Published: (2023-09-01)

Risk Scores Based on Six Survival-Related RNAs in a Competing Endogenous Network Composed of Differentially Expressed RNAs Between Clear Cell Renal Cell Carcinoma Patients Carrying Wild-Type or Mutant Von Hippel–Lindau Serve Well to Predict Malignancy and Prognosis
by: Rui Zhu, et al.
Published: (2021-10-01)

The roles of VHL-dependent ubiquitination in signaling and cancer
by: Qing eZhang, et al.
Published: (2012-04-01)

Metabolic reprogramming of clear cell renal cell carcinoma
by: Haiyan Zhu, et al.
Published: (2023-06-01)

MicroRNA Associated with the Invasive Phenotype in Clear Cell Renal Cell Carcinoma: Let-7c-5p Inhibits Proliferation, Migration, and Invasion by Targeting Insulin-like Growth Factor 1 Receptor
by: Thomas J. Kalantzakos, et al.
Published: (2022-09-01)

Targeting the Deterministic Evolutionary Trajectories of Clear Cell Renal Cell Carcinoma
by: Adam Kowalewski, et al.
Published: (2020-11-01)

Fibroblast growth factor receptor type 4 as a potential therapeutic target in clear cell renal cell carcinoma
by: Takafumi Narisawa, et al.
Published: (2023-02-01)

Multi-Omics Profiling to Assess Signaling Changes upon VHL Restoration and Identify Putative VHL Substrates in Clear Cell Renal Cell Carcinoma Cell Lines
by: Xuechun Wang, et al.
Published: (2022-01-01)

Two tests of peripheral blood by standard methods were negative for Von Hippel-Lindau mutations: A case report
by: Bing Deng, et al.
Published: (2023-09-01)

Von Hippel-Lindau Disease
by: Hes Frederik J, et al.
Published: (2005-11-01)

Pathological and Clinical Features and Management of Central Nervous System Hemangioblastomas in von Hippel-Lindau Disease
by: Hiroshi Kanno, et al.
Published: (2014-08-01)

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
by: Cesar U. Monjaras-Avila, et al.
Published: (2023-04-01)

Cuprotosis-related signature predicts overall survival in clear cell renal cell carcinoma
by: Fan Zhang, et al.
Published: (2022-09-01)

Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease
by: Virginia Albiñana, et al.
Published: (2020-08-01)

<i>ENO2</i> as a Biomarker Regulating Energy Metabolism to Promote Tumor Progression in Clear Cell Renal Cell Carcinoma
by: Jian Shi, et al.
Published: (2023-09-01)

Up-regulated PIF1 predicts poor clinical outcomes and correlates with low immune infiltrates in clear cell renal cell carcinoma
by: Tong Cai, et al.
Published: (2023-01-01)

Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma
by: Corina Daniela Ene, et al.
Published: (2023-12-01)

Implications of Von Hippel-Lindau Syndrome and Renal Cell Carcinoma
by: Kenan Ashouri, et al.
Published: (2015-09-01)

Identification of a Novel Stem Cell Subtype for Clear Cell Renal Cell Carcinoma Based on Stem Cell Gene Profiling
by: Hongzhi Wang, et al.
Published: (2021-11-01)

Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment
by: Zhulin Wu, et al.
Published: (2020-11-01)

Von Hippel-Lindau disease associated with myasthenia gravis not related to thymoma
by: Paolo Pozzato, et al.
Published: (2013-04-01)

A novel mutation identified in a patient with pheochromocytoma and renal cell carcinoma
by: Jae Wan Kwon, et al.
Published: (2018-12-01)

Whole-Exome Sequencing Identifies the VHL Mutation (c.262T > C, p.Try88Arg) in Non-Obstructive Azoospermia-Associated Cystic Renal Cell Carcinoma
by: Yonghong Man, et al.
Published: (2022-03-01)

A Three-Metabolic-Genes Risk Score Model Predicts Overall Survival in Clear Cell Renal Cell Carcinoma Patients
by: Yiqiao Zhao, et al.
Published: (2020-10-01)

The Impact of Image Acquisition Parameters and ComBat Harmonization on the Predictive Performance of Radiomics: A Renal Cell Carcinoma Model
by: Abdalla Ibrahim, et al.
Published: (2022-09-01)

Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
by: Laura K. Esser, et al.
Published: (2020-09-01)

Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease
by: Cristina Suarez, et al.
Published: (2022-10-01)

Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma
by: Mancheng Gong, et al.
Published: (2023-10-01)